Warning: include(wp-includes/js/tinymce/themes/advanced/img.php) [function.include]: failed to open stream: No such file or directory in /home/ctc_aa/nationalaidsstrategy.org/blog/wp-blog-header.php(7) : eval()'d code(1) : eval()'d code on line 1

Warning: include() [function.include]: Failed opening 'wp-includes/js/tinymce/themes/advanced/img.php' for inclusion (include_path='.:/usr/local/lib/php:/usr/local/php5/lib/pear') in /home/ctc_aa/nationalaidsstrategy.org/blog/wp-blog-header.php(7) : eval()'d code(1) : eval()'d code on line 1
Coalition for a National AIDS Strategy
Coalition for a National AIDS Strategy

This event is inactive
Sun, Jul 22, 2012
11:15 AM - 1:15 PM

From Revolution to Reality: How Will New Science Impact the US National HIV/AIDS Strategy?

AIDS 2012 Conference Satellite - Free and open to the public

BREAKING: We will be serving a boxed lunch for the first 150 attendees!

RSVP requested.

Sunday, July 22, 2012, 11:15 AM -1:15 PM

Mini Room 4, Walter E. Washington Convention Center, Washington, DC

Hosted by the Coalition for a National HIV/AIDS Strategy

Moderator: Marjorie J. Hill, PhD, CEO, Gay Men's Health Crisis 

Presenters include:

  • Carlos del Rio, MD, Hubert Professor and Chair, Hubert Department of Global Health, Emory University: Treatment Cascade
  • Keith R. Green, MSW, Director of Federal Affairs, AIDS Foundation of Chicago: PrEP and the NHAS
  • David R. Holtgrave, PhD, Chair, Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health: Costs, Consequences and Feasibility of Achieving the NHAS Goals
  • Molly Morgan Jones, PhD, Senior Analyst, RAND Europe: Mapping Pathways: Exploring strategies in the use of ARV-based prevention


The U.S. National HIV/AIDS Strategy (NHAS) has been in place for two years, and since its release, scientific breakthroughs and new research have transformed our thinking about the US HIV epidemic.  HPTN 052 and successful PrEP and microbicide trials demonstrate that biomedical interventions hold promise that were unthinkable just 2 years ago.  

At the same time, Gardner and his coauthors shine a spotlight on the human factors impacting the epidemic-half of people with HIV are not in medical care, and just 1 in 4 achieves treatment success.  Key researchers, including some who contributed to these breakthrough findings, will weigh in on the implications of new research on the US strategy.

This session will be immediately followed by the satellite session, "
Achieving the Goals of the United States National HIV/AIDS Strategy: Next steps", organized by the U.S. Department of Health and Human Services. 

This symposium is conducted in collaboration with and funded by Bristol-Myers Squibb with no editorial review of content.

Event Location

Mini Room 4, Walter E. Washington Convention Center, Washington,
Washington, DC